Calcium dyshomeostasis in beta-amyloid and tau-bearing skeletal myotubes

Rial A Christensen1, Alexander Shtifman, Paul D Allen

  • 1Department of Neurology, Caritas St. Elizabeth's Medical Center, Tufts University School of Medicine, 736 Cambridge St., Boston, MA 02135, USA.

Insights

Alzheimer's Disease proteins, beta-amyloid and Tau, disrupt muscle calcium regulation and cause Tau hyperphosphorylation in inclusion body myositis. This study reveals how these proteins contribute to muscle weakness by affecting calcium handling.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Neuroscience

Background:

  • Inclusion Body Myositis (IBM) shows few dying muscle cells, unlike Alzheimer's Disease (AD) which has early protein deposits.
  • The study investigates the link between beta-amyloid and Tau accumulation in muscle cells and calcium mishandling in IBM patients.

Purpose of the Study:

  • To examine the correlation between myotube beta-amyloid and/or Tau accumulations and intracellular muscle calcium concentration.
  • To understand the mechanism behind muscle weakness in IBM patients.

Main Methods:

  • Cultured myogenic cells (C(2)C(12)) were engineered to express beta-amyloid-42 (Abeta(42)) and fetal Tau peptides.
  • Calcium levels were measured using calcium-specific microelectrodes and Fluo-4 epifluorescence.
  • Ryanodine receptor sensitivity to calcium release was assessed.

Main Results:

  • Co-expression of Abeta(42) and Tau led to Tau hyperphosphorylation.
  • Combined Abeta(42) and Tau expression increased basal myoplasmic-free calcium levels and plasma membrane depolarization.
  • Abeta(42) or Tau expression, individually or together, enhanced ryanodine receptor sensitivity to caffeine, indicating altered calcium release.
  • Beta-amyloid expression alone increased sensitivity to caffeine.

Conclusions:

  • Amyloid proteins synergistically elevate resting calcium levels in muscle cells.
  • These effects are linked to passive sarcoplasmic reticulum (SR) calcium leak and Tau hyperphosphorylation.
  • The findings suggest a novel mechanism contributing to muscle weakness in IBM.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...